28 results
424B5
CNTA
Centessa Pharmaceuticals plc
13 Sep 24
Prospectus supplement for primary offering
4:02pm
limited company incorporated under the laws of England and Wales.
Overview
We are a clinical-stage pharmaceutical company with a mission to discover
424B5
CNTA
Centessa Pharmaceuticals plc
11 Sep 24
Prospectus supplement for primary offering
4:40pm
-stage pharmaceutical company with a mission to discover, develop and ultimately deliver medicines that are transformational for patients. We
8-K
EX-99.2
CNTA
Centessa Pharmaceuticals plc
10 Sep 24
Regulation FD Disclosure
7:08am
inherent in developing products and technologies; future results from our ongoing and 2
OUR MISSION Discovering and developing medicines … LOCKBODY TECHNOLOGY PLATFORM LB101 Phase 1/2 study ongoing 35
OUR MISSION Discovering and developing medicines that are transformational for patients
DEFA14A
CNTA
Centessa Pharmaceuticals plc
20 May 24
Additional proxy soliciting materials
8:48pm
to our mission. We remain deeply committed to keeping patients at the center of all that we do. This focus affirms our purpose and inspires us to pursue … with the Companies Act requirements for the Strategic Report.
Principal Activities
We are a clinical-stage pharmaceutical company with a mission to discover
424B5
1oit32jym8uxcsc6n
24 Apr 24
Prospectus supplement for primary offering
8:53pm
424B5
99x37m98 2zdb
23 Apr 24
Prospectus supplement for primary offering
5:16pm
8-K
EX-99.2
pqz2h74n5ar
22 Apr 24
Regulation FD Disclosure
7:15am
8-K
EX-99.1
tnobc
9 Jan 24
Regulation FD Disclosure
7:56am
DEFA14A
z0qd0mby4c noma3tj
23 May 23
Additional proxy soliciting materials
4:08pm
DEFA14A
jxwpb1z
9 Jun 22
Additional proxy soliciting materials
9:06am
10-K
43e9n9eh 0u
30 Mar 22
Annual report
12:00am